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OBJECTIVE — To assess the effects of leisure-time physical activity (LTPA) and resistance
training on metabolic syndrome (MetS) and its components in a post hoc analysis of the Finnish
Diabetes Prevention Study, a randomized controlled lifestyle counseling trial.
RESEARCH DESIGN AND METHODS — A cohort of 486 middle-aged overweight
men and women with impaired glucose tolerance were followed for an average of 4.1 years. The
intervention and control groups were combined in the analyses. LTPA was assessed by ques-
tionnaires, dietary intake by food records, and features of the MetS by anthropometric and
biochemical measures annually. Resistance training sessions were documented for 137
participants.
RESULTS — Increased moderate-to-vigorous LTPA, even after adjustments for changes in
dietary intakes of total and saturated fat, ﬁber, and energy, and change in BMI was associated
with a greater likelihood for resolution (29.7 vs. 19.1%; P  0.004 in the upper versus lower
thirdofchange)andalesserlikelihoodfordevelopment(23.5vs.44.7%;P0.041)oftheMetS.
Of the components of the MetS, the increase in moderate-to-vigorous LTPA was associated most
strongly with improvement of glycemia. Among the 137 participants who participated in resis-
tance training, MetS components were favorable in individuals who were in the upper third of
participationrate(median51times/year)comparedwithindividualsinthelowestthird(median
8.5 times/year).
CONCLUSIONS — Increased moderate-to-vigorous LTPA was associated with a decreased
likelihood of developing the MetS and an increased likelihood of its resolution in individuals at
high risk for type 2 diabetes.
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T
he metabolic syndrome (MetS) is a
constellationofinterrelatedmetabolic
riskfactors,includingabdominalobe-
sity, insulin resistance, hyperglycemia,
dyslipidemia, and elevated blood pres-
sure,oftenaccompaniedbyaprothrom-
botic and proinﬂammatory state (1,2).
The underlying pathophysiology of the
MetS is unclear, but both insulin resis-
tanceandabdominalobesityareconsid-
ered main components (1,2). The MetS
increasestheriskofbothtype2diabetes
(3) and cardiovascular disease (4,5).
Recent recommendations for the pre-
vention and treatment of the MetS and its
components promote increased physical
activity (including aerobic and resistance
exercise), a healthy diet, and weight loss
(2,6–8). In lifestyle interventions trials,
the incidence of type 2 diabetes has been
reduced by more than half in individuals
with impaired glucose tolerance, and the
prevalence of the MetS has also been de-
creased (9,10). In the Finnish Diabetes
Prevention Study (DPS), increased mod-
erate-to-vigorous leisure-time physical
activity (LTPA) was strongly associated
with a lower risk of type 2 diabetes, inde-
pendently of dietary changes and weight
loss (11).
Some prospective epidemiological
studies and uncontrolled trials have
suggested that increased moderate-to-
vigorous exercise decreases the incidence
or prevalence of the MetS (8,12,13).
However, data on the role of changes in
LTPA in the prevention and treatment of
the MetS in long-term studies are limited.
Therefore, we conducted a post hoc anal-
ysis of the Finnish DPS. Our hypothesis
was that the change in LTPA and partici-
pation in resistance training would be as-
sociated with the change in the MetS and
its components.
RESEARCH DESIGN AND
METHODS— A detailed description
of the design, subjects, and methods ap-
plied in the DPS has been reported previ-
ously (14). In brief, the DPS was a
randomizedlifestyleinterventionstudyin
522 middle-aged overweight participants
withimpairedglucosetolerance,aimedat
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presentstudy,weincludedthose486par-
ticipants(249intheinterventionand237
in the control group) who had completed
aquestionnairequantifyingLTPAatbase-
line and during yearly follow-up visits
(11). A subgroup of 137 participants was
taking part in supervised resistance train-
ing sessions. The study protocol was ap-
proved by the ethics committee of the
National Public Health Institute in Hel-
sinki, and all subjects gave written in-
formed consent.
Intervention
The aim of the intervention was to en-
courage people to make healthy lifestyle
choices. The participants in the interven-
tion group were given detailed and
individualized dietary and exercise coun-
seling as described elsewhere (15). En-
durance exercise was recommended to
increaseaerobiccapacityandcardiorespi-
ratory ﬁtness. Session for supervised and
individually tailored progressive circuit-
typeresistancetrainingwithmoderatein-
tensity were recommended twice a week
and offered free of charge in three of the
ﬁve study centers.
The participants in the control group
were given general information about
healthy food choices, physical activity,
and weight loss at baseline, but no indi-
vidualized counseling was offered.
Assessment of physical activity
The validated Kuopio Ischemic Heart
Disease risk factor study questionnaire
(11,12) was used for the assessment of
physical activity. The participants esti-
mated the frequency, average duration,
andintensityofdifferentformsofexercise
for individual months during the past 12
months. Based on the reported intensity
of different activities and their corre-
sponding metabolic equivalent (MET)
values,thetotalLTPAwasdividedtolow-
intensity and to moderate-to-vigorous in-
tensity LTPA (13). Low-intensity LTPA
(3.5 METs) included activities such as
gardening, picking berries, casual walk-
ing, and bicycling at recreational inten-
sity. Moderate-to-vigorous LTPA (3.5
METs) included activities such as brisk
walking,jogging,skiing,swimming,row-
ing, forest work, gymnastics, resistance
training, ball games, snow shoveling, and
heavy housework.
The duration of total LTPA and its
components were calculated as hours/
week from the baseline to the end of the
follow-up. The changes were calculated
by subtracting averaged follow-up value
from the corresponding baseline value
(11). The participation in resistance
training was recorded electronically
when the participants visited the resis-
tance training facilities and was ana-
lyzed as sessions/year.
Other measurements
Medical history and 3-day food records
were collected at baseline and at each an-
nualvisit.Averageintakesofenergy(kcal/
day), carbohydrates (E%), total fat (E%),
saturated fat (E%), and dietary ﬁber (g/
1,000 kcal) were calculated. The average
values from years 1–3 were used to mea-
sure dietary intakes during follow-up
(11).
Anthropometry and blood pressure
were assessed as described previously.
Plasma glucose was determined locally
according to standard guidelines. Se-
rum total and HDL cholesterol and tri-
glyceride levels were determined by
enzymatic methods (Boehringer Mann-
heim, Germany).
For the deﬁnition of the MetS, we
used the National Cholesterol Education
Program 2005 criteria (6).
Statistical analysis
The data were analyzed using SPSS statis-
tical software (version 11.5; SPSS, Chi-
cago, IL). The baseline values are given as
mean  SD, as median with 0.25–0.75
interquartilerange,oraspercentages.The
Student two-tailed t test, Mann-Whitney
U test (fasting and 2-h serum insulin, tri-
glycerides, and LTPA), and 
2 test were
applied to compare the differences at
baseline and during the follow-up. For
participants who dropped out or devel-
oped diabetes during the study, the mea-
surementsatthelastobservationyearwas
used as the end value.
The primary outcome measure was
the change in the MetS status in the com-
bined intervention and control group
frombaselinetotheend,i.e.,resolutionof
the MetS from baseline, development of
MetS, or no change with LTPA changes as
explanatory variables. Secondary out-
come measures were the changes of the
MetS components. The change of differ-
entLTPAwascategorizedintothirds.The
associationwiththechangeinMetSstatus
and its components was analyzed with
multinominal regression. The models
were adjusted for age, sex, intervention
group, and DPS study years (model 1)
with further adjustments for changes in
diet(intakeoftotalfat,saturatedfat,ﬁber,
and energy) (model 2) and BMI (model
3).Thechangeinlow-intensityLTPAwas
also adjusted for the change in moderate-
to-vigorous LTPA and vice versa. P values
0.05 were considered statistically
signiﬁcant.
RESULTS
Baseline clinical and metabolic
characteristics
Inthecombinedstudycohort,74.3%had
the MetS at baseline. The participants
withtheMetSatbaselinehadsigniﬁcantly
higher BMI, waist circumference, blood
pressure, fasting and 2-h glucose, fasting
and 2-h insulin, and serum triglyceride
levels and lower serum HDL cholesterol
levels (Table 1).
In general, men exercised more than
women. Women without the MetS re-
ported signiﬁcantly more hours per week
spent on total and low-intensity LTPA
during the previous 12 months than
women with the MetS.
Changes in LTPA during the
follow-up
ThemedianfortotalLTPAincreasedfrom
7.2(3.6–10.8)atbaselinetoanaverageof
7.7 (4.8–11.7) hours per week (P 
0.061) in men and from 5.3 (2.8–8.6) to
5.8(3.2–9.0)hoursperweek(P0.016)
in women during the follow-up. The me-
dian for moderate to vigorous LTPA in-
creased from 2.3 (0.9–4.8) to 3.1 (1.8–
4.9) (P  0.001) hours per week in men
and from 1.4 (0.3–3.5) to 2.5 (1.1–4.1)
(P  0.001) hours per week in women.
There was no signiﬁcant change in low-
intensity LTPA.
LTPA changes and the incidence for
resolution and development of the
MetS
Of the 361 participants meeting the
MetS criteria at baseline, 20.8% (n 
75; 26.6% in the intervention and
14.7% in the control group; P  0.005)
showed resolution during the follow-
up. Of the 126 participants not meeting
the MetS criteria at baseline, 31.2%
(n  39; 30.8% in the intervention and
31.7% in the control group; P  0.95)
developed MetS during the follow-up.
The development of the MetS was asso-
ciatedwithweightgainandlessLTPAin
both groups.
The change in total LTPA was associ-
ated with the change in MetS status (res-
olution, no change, development) after
adjustment for age, sex, intervention
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1A) and dietary intakes (model 2, Fig.
1A). The change in moderate-to-vigorous
LTPA was even more strongly associated
withthechangeinMetSstatusinanalyses
adjusting for the variables in model 1 and
changes in low-intensity LTPA. The reso-
lutionoftheMetSwasseenin29.7versus
19.1% (P  0.004), and the development
of MetS was seen in 23.5 versus 44.7%
(P  0.041) in the upper versus lower
third of change in moderate-to-vigorous
LTPA. The associations remained signiﬁ-
cantafterfurtheradjustmentsforchanges
in diet (model 2) and BMI (model 3) (Fig.
1B). Changes in low-intensity LTPA were
not associated with the change in MetS
status (Fig. 1C).
LTPA changes and the components
of the MetS
The increase in total LTPA was associated
with a decrease in the prevalence of hyper-
glycemia (P  0.020–0.053), low HDL
cholesterol(P0.018–0.057),andhyper-
triglyceridemia (P  0.002–0.003) (Table
2). Increased moderate-to-vigorous LTPA
decreased the prevalence of elevated fasting
glucose (P  0.003–0.018), but no associ-
ation with abdominal obesity (P  0.065–
0.181), low HDL cholesterol (P  0.098–
0.232), and high blood pressure (P 
0.068–0.151) was found. In contrast, an
increase in low-intensity LTPA was associ-
ated with an improvement in hypertriglyc-
eridemia (P  0.006–0.004), but not any
of the other components of the MetS.
Resistance training and the
components of the MetS
In the subgroup of 137 individuals taking
part in supervised resistance training, the
median attendance rate was 27.0 (13.4–
42.9) sessions/year during the entire study.
Of the MetS status components, the resis-
tance training attendance rate was associ-
ated, even after adjustment for dietary and
BMIchanges,withimprovementsinhyper-
glycemia (P0.127–0.029), hypertriglyc-
eridemia(P0.046–0.081),andlowHDL
cholesterol (P  0.001–0.002), but not
with elevated blood pressure or abdominal
obesity (Table 3).
CONCLUSIONS — Increased mod-
erate-to-vigorous LTPA during the 4.1-
Table 1—Baseline characteristics of the participants according the absence (MetS
) or presence (MetS
) of the MetS
All MetS
 MetS
 P
n 486 125 361 —
Group allocation 0.843
Intervention 249 65 184
Control 237 60 177
Sex 0.003
Male n (%) 162 (33.3) 55 (34.0) 107 (66.0)
Female n (%) 324 (66.7) 70 (21.6) 254 (78.4)
Age (years) 55.4  7.0 55.8  7.1 55.3  7.0 0.476
40–49 (%) 27.0 27.2 26.9
50–59 (%) 33.1 28.8 34.6
60 (%) 39.9 44.0 38.0
Weight (kg) 86.3  14.3 80.3  10.0 88.4  14.9 0.001
BMI (kg/m
2) 31.2  4.5 28.8  3.4 32.1  4.6 0.001
Waist (cm) (all) 101.2  11.0 94.7  8.1 103.5  11.0 0.001
Men 104.2  9.7 97.3  6.0 107.7  9.4
Women 99.8  11.4 92.7  9.0 101.7  11.2
Fasting glucose (mmol/l) 6.1  0.7 5.8  0.7 6.3  0.7 0.001
2-h glucose (mmol/l) 8.9  1.5 8.6  1.4 9.0  1.5 0.014
Fasting insulin (mU/l) 13 (10–18) 10 (8–13) 14 (11–19) 0.001
2-h insulin (mU/l) 79 (54–120) 60 (38–77) 89 (63–134) 0.001
Serum total cholesterol (mmol/l) 5.6  0.9 5.7  0.8 5.6  0.9 0.064
Serum HDL cholesterol (mmol/l) 1.21  0.29 1.39  0.24 1.15  0.28 0.001
Serum triglycerides (mmol/l) 1.56 (1.18–2.09) 1.20 (0.96–1.43) 1.72 (1.34–2.29) 0.001
Lipid-lowering medication (%) 5.4 3.2 6.2 0.576
Systolic blood pressure (mmHg) 138  18 133  20 140  16 0.001
Diastolic blood pressure (mmHg) 86  10 82  11 87  9 0.001
Antihypertensive medication (%) 35.3 16.8 41.7 0.001
Total LTPA (all) (h/week) 5.7 (3.1–9.3) 6.9 (4.3–10.1) 5.1 (2.8–9.1) 0.001
Men 7.2 (3.6–10.8) 7.5 (3.8–10.4) 6.9 (3.4–10.9) 0.503
Women 5.3 (2.8–8.6) 6.7 (4.3–9.8) 4.9 (2.6–8.2 ) 0.002
Moderate-to-vigorous LTPA (all) 1.7 (0.5–4.0) 1.9 (0.6–4.4) 1.6 (0.4–3.8) 0.165
Men 2.3 (0.9–4.8) 2.1 (1.1–4.7) 2.4 (0.7–4.9) 0.725
Women 1.4 (0.3–3.5) 1.7 (0.4–4.2) 1.3 (0.3–3.5) 0.481
Low-intensity LTPA 3.0 (1.2–5.9) 4.1 (1.9–7.2) 2.9 (1.1–5.3) 0.004
Men 3.2 (1.4–6.9) 3.7 (1.9–7.2) 3.0 (1.2–6.9) 0.268
Women 2.9 (1.2–5.6) 4.4 (1.5–7.2) 2.8 (1.1–4.6) 0.011
Data are means  SD for normally distributed or medians (interquartile ranges) for skewed parameters or percentages.
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for the MetS to resolve and decreased the
likelihood for the MetS to develop, inde-
pendently of changes in diet and body
weight. Moreover, increased moderate-
to-vigorous LTPA decreased the preva-
lence of hyperglycemia. Improvements in
fasting plasma glucose, serum triglycer-
ides,andHDLcholesterol,independently
of changes in diet, lifestyle LTPA, and
other types of LTPA, were associated with
participation in resistance training.
Overall, strong and mostly linear
dose-response associations of the change in
total LTPA with the development and
resolution of the MetS were seen. When
breaking down physical activity into
moderate-to-vigorous LTPA and low-
intensity LTPA, it seems evident that
most of the beneﬁt was from moderate-
to vigorous-intensity LTPA. Changes in
moderate-to-vigorous LTPA were asso-
ciated with the change in metabolic sta-
tus, even independently of the changes
in BMI, but the association was not lin-
ear across categories. Changes in low-
intensity LTPA were not associated with
the development or resolution of the
MetS. Why the dose-response associa-
tion was not apparent for moderate-to-
vigorous LTPA is unclear, but it may be
related to the difﬁculty in the precise
assessment of LTPA. Overall, however,
our ﬁndings support efforts to increase
or at least maintain LTPA, especially
moderate-to-vigorous LTPA, in the pre-
vention and treatment of the MetS.
In this analysis of the DPS, the in-
tervention and control groups were
combined. In separate analysis, there
was a signiﬁcant difference between the
groups in the resolution of the MetS.
However, there was no difference in the
development of MetS between groups;
	30%ofthosewithoutMetSatbaseline
developed MetS in both groups during
the follow-up. This may be due the se-
lection of the participants. They were
individuals at high risk for type 2 dia-
betes and for the MetS. During the fol-
low-up, 22% developed type 2 diabetes
(11). While the development of MetS
wasassociatedwithweightgainandless
LTPA, those subjects who developed
the MetS appeared to not adhere with
our intervention. The apparent favor-
able effects of moderate-to-vigorous
LTPA on resolution and development of
the MetS are consistent with the results
of the uncontrolled Heritage Family
Study(16)andsomeprospectivecohort
studies showing that increased moder-
Figure1—Incidences(%)forthedevelopment(forindividualswithoutMetSatbaseline,n125)
( )andtheresolution(forindividualswithMetSatbaseline,n361)(f)oftheMetSaccording
to LTPA change tertiles for total LTPA (A), moderate-to-vigorous LTPA (B), and low-intensity
LTPA(C).Model1:adjustmentsforage,sex,interventiongroup,andDPSstudyyears.Thechange
inlow-intensityLTPAwasalsoadjustedforchangeinmoderate-to-vigorousLTPAandviceversa.
Model2:model1andadjustmentsforchangeindietaryintakesoftotalfat,saturatedfat,ﬁber,and
energy. Model 3: model 2 and change in BMI.
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with a lower incidence of the MetS dur-
ing follow-up (8,12,17). In the DPS co-
hort, increased moderate-to-vigorous
LTPA seemed to protect against devel-
oping the MetS in both men and
women. Higher cardiorespiratory ﬁt-
ness, which partly reﬂects higher levels
of moderate-to-vigorous LTPA, has pre-
dicted a lower prevalence of the MetS
independently of major confounding
variables also in women in the Aerobics
Center Longitudinal Study (18) and
in the Dose-ResponsestoExerciseTraining
Study (19). Changes in low-intensity
LTPAwerenotassociatedwithchangesin
the MetS status. These ﬁndings are con-
sistentwiththeresultsoftheKuopioIsch-
emic Heart Disease study, in which
moderate-to-vigorous, but not low-
intensity, LTPA was associated with de-
velopment of the MetS (12). When
examining speciﬁc components of the
MetS, increased moderate-to-vigorous
LTPA had the greatest effect on impaired
fastingglucose,whereasthebeneﬁtonab-
dominal obesity, low HDL cholesterol,
and high blood pressure was not signiﬁ-
cant.Incontrast,changesinlow-intensity
LTPA had beneﬁts on hypertriglyceride-
mia, but not on the other components of
the MetS, and changes in total LTPA im-
proved impaired fasting glucose and
dyslipidemia.
In intervention trials, low-intensity
LTPAhaslessconsistentlyimprovedmet-
abolic outcomes than more intense LTPA
(8). However, we have previously re-
ported that increased low-intensity and
moderate-to-vigorous LTPA were simi-
larly associated with a lower risk of type 2
diabetes in the Finnish DPS, suggesting
that total energy expenditure on LTPA
was more important than intensity (11).
In line with that ﬁnding, the accumulated
daily physical activity as measured with
an accelerometer was a major determi-
nant of insulin sensitivity, and time spent
onmoderate-to-vigorousphysicalactivity
did not affect insulin sensitivity indepen-
dently of total activity in the European
Relationship between Insulin Sensitivity
and Cardiovascular Risk Study (20). The
differences may be explained by differ-
ences in study populations and speciﬁc
metabolic outcomes. More information
on the long-term metabolic beneﬁts of
low-intensity LTPA in different age-
groups and risk groups is nonetheless
needed.
Regular participation in resistance
training predicted favorable changes in
MetS components. We found that a
higher participation rate in resistance
training was associated with beneﬁts on
impaired fasting glucose, hypertriglyc-
eridemia, and low HDL cholesterol, but
not abdominal obesity or blood pres-
sure. In 3- to 6-month trials, resistance
training has variably increased muscle
mass,decreasedfatmassandabdominal
obesity, and improved insulin sensitiv-
ity in obese adults, hypertensive pa-
tients, older men, and older type 2
diabetic patients (8,21,22). In individ-
uals with type 2 diabetes, resistance
training resulted in similar improve-
ments of glycemic control as aerobic ex-
ercise (23), although the effect on
glucose tolerance in impaired glucose
tolerance has been less clear (8). Im-
provements in insulin sensitivity and
metabolic risk factors may be mediated
inpartbychangesinbodycomposition,
but strength training may also indepen-
dently affect steps in insulin signaling
and glucose transport (24). Based on
meta-analyses of trials, resistance train-
ing may decrease blood pressure (25),
but effects on dyslipidemia have been
variable (8).
Our ﬁndings suggest that there is a
graded beneﬁt in the frequency of resis-
tance training in the prevention or treat-
ment of the MetS components, with
rather substantial beneﬁts for individuals
engaging in resistance training on median
once a week compared with individuals
engaging in resistance training on median
less than once a month. In the above-
mentioned studies showing an improve-
ment in insulin sensitivity in individuals
Table2—Incidences(%)fordevelopmentandresolutionoftheMetScomponentsaccordingtoLTPAchangetertilesfortotal,low-intensity,and
moderate-to-vigorous LTPA during the follow-up
Tertiles for total LTPA change median
(0.25–0.75 interquartile range) (h/week)
Incidence
(%)
Lower
3.2 (5.5 to 1.6)
Middle
0.6 (0.1 to 1.2)
Upper
3.8 (2.4 to 5.8)
P for
trend
Abdominal obesity 0.119*
Development 4.3% 7.4 2.5 3.1 0.184†
Resolution 11.1% 8.6 12.3 12.3 0.408‡
Elevated fasting glucose 0.020*
Development 12.4% 17.4 13.0 6.8 0.033†
Resolution 8.9% 8.1 10.5 8.0 0.053‡
Elevated triglycerides 0.002*
Development 9.3% 11.1 6.8 9.9 0.002†
Resolution 14.4% 6.2 20.4 16.7 0.003‡
Low HDL cholesterol 0.018*
Development 7.8% 12.3 6.8 4.3 0.013†
Resolution 16.5% 13.6 13.6 22.6 0.057‡
Elevated blood pressure 0.661*
Development 4.7% 5.6 5.6 3.1 0.643†
Resolution 9.7% 8.0 9.3 11.8 0.800‡
*Model1:adjustmentsforage,sex,interventiongroup,andDPSstudyyears.Thechangeinlow-intensityLTPAwasalsoadjustedforchangeinmoderate-to-vigorous
LTPA and vice versa. †Model 2: model 1 and adjustments for change in dietary intakes of total fat, saturated fat, ﬁber, and energy. ‡Model 3: model 2 and change
in BMI.
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control in patients with type 2 diabetes,
training frequency was generally two to
three times per week. The metabolic ben-
eﬁts of resistance training at a lower fre-
quency may become apparent only after
much longer periods of training than in
previously published trials, which have
usually lasted 3–6 months. However,
longer-term trials are needed to test this
hypothesis.
Strengths of the DPS include its re-
peated assessments of LTPA and dietary
intake. However, the present analyses are
post hoc. Furthermore, the intervention
had several components. Detailed assess-
ment of the individual lifestyle compo-
nentsallowsstatisticaldisentanglementof
their individual effects, but residual con-
founding is possible. Moreover, we did
not objectively measure physical activity.
Decreases in LTPA may have been related
to factors that themselves may be related
to the development of the MetS. Adher-
ence to resistance training was on average
poor. When this study was conducted in
the early 1990s, it was uncommon for
middle-aged and overweight individuals
to attend resistance training facilities,
where most of the clientele were young
andﬁt.Somealsoencountereddifﬁculties
with transportation and time schedules.
In conclusion, increased participa-
Table 2—Continued
Tertiles for low LTPA change median
(0.25–0.75 interquartile range) (h/week)
Tertiles for moderate-to-vigorous LTPA change median
(0.25–0.75 interquartile range) (h/week)
Lower
3.2 (5.6 to 1.7)
Middle
0.1 (0.4 to 0.5)
Upper
3.1 (1.8 to 5.1)
P for
trend
Lower
1.5 (3.1 to 0.5)
Middle
0.5 (0.2 to 0.8)
Upper
2.6 (1.8 to 3.8)
P for
trend
0.718* 0.065*
4.9 4.9 3.0.1 0.753† 6.2 2.5 4.3 0.083†
12.3 10.5 10.5 0.725‡ 9.3 6.8 4.3 0.181‡
0.941* 0.003*
11.8 12.3 13.0 0.928† 19.1 11.7 6.2 0.011†
7.5 9.3 9.9 0.984‡ 8.6 8.0 9.9 0.018‡
0.006* 0.491*
9.9 6.2 11.7 0.005† 12.3 8.0 7.4 0.526†
8.0 19.3 16.0 0.004‡ 14.9 12.4 16.0 0.672‡
0.762* 0.098*
7.4 9.3 6.8 0.668† 11.7 6.2 5.6 0.086†
16.7 14.2 18.5 0.807‡ 14.8 13.6 21.3 0.232‡
0.921* 0.068*
4.9 4.3 5.0 0.883† 7.4 4.3 2.5 0.066†
9.9 11.1 8.1 0.824‡ 6.8 8.0 14.3 0.151‡
Table 3—The average resistance training attendance rate per year and the change (development and resolution) in the MetS components
among a subgroup of 137 participants
Tertiles for average yearly attendance rate for resistance training median
(0.25–0.75 interquartile range)
Incidence (%)
(n  137)
Lower
8.5 (5.5–13.4)
Middle
27.0 (21.9–32.7)
Upper
50.7 (42.3–67.2) P
Abdominal obesity 0.438*
Development 0.0 0.0 0.0 0.0 0.537†
Resolution 10.2 4.4 13.0 13.0 0.549‡
Elevated fasting glucose 0.127*
Development 16.8 13.3 26.1 10.9 0.157†
Resolution 5.1 6.7 2.2 6.5 0.029‡
Elevated triglycerides 0.046*
Development 10.2 11.1 17.4 2.2 0.067†
Resolution 20.4 11.1 21.7 28.3 0.081‡
Low HDL cholesterol 0.000*
Development 10.9 15.6 17.4 2.2 0.001†
Resolution 18.2 6.7 26.1 21.7 0.002‡
Elevated blood pressure 0.982*
Development 3.6 4.4 2.2 4.3 0.967†
Resolution 10.2 8.9 10.9 10.9 0.957‡
*Model1:adjustmentsforage,sex,group,DPSstudyyears,averagedlow-intensityLTPA,andLTPAotherthangymnasticsandcalisthenics.†Model2:model1and
adjustments for change in dietary intakes of total fat, saturated fat, ﬁber, and energy. ‡Model 3: adjustment for model 2 and change in BMI.
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activity and regular long-term partici-
pation in resistance training improved
the MetS status among men and women
with impaired glucose tolerance in the
FinnishDPS.Physicalactivityandresis-
tancetrainingalsomorespeciﬁcallyhad
beneﬁts with respect to hyperglycemia
and dyslipidemia, but improvements in
abdominal obesity were not clearly
seen. Resolution or prevention of the
MetS and related features might con-
tribute to the protective effect of physi-
cal activity on type 2 diabetes.
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